Ledger.Open graph →
SEC Form D · filed July 24, 2014

EYEGATE PHARMACEUTICALS INC

Offering
$2.0M
Sold
$995K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Thomas Balland · Paris, I0DirectorStephen From · Waltham, MAExecFrancis Sapienza · Dallas, TXExecLeslie Deshazer · Dallas, TXDirectorPraveen Tyle · Waltham, MADirectorBernard Malfoye-Camine · Waltham, MADirectorMorton Goldberg · Waltham, MADirectorMounia Chaoui · Puteaux, I0DirectorPaul Chaney · Melville, NYDirectorThomas Hancock · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗